+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients: Single-center Experience From Poland



Long-term Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients: Single-center Experience From Poland



Transplantation Proceedings 50(7): 2128-2131



Simultaneous pancreas-kidney transplantation (SPKT) is the treatment of choice for patients with end-stage renal disease (ESRD) due to type 1 diabetes mellitus (DM1). Since the 1980s, pancreas transplantation has become the most effective strategy to restore normoglycemia in patients with DM1. The aim of this study was to present long-term outcomes data for SPKT. We performed a retrospective analysis of 73 SPKT recipients followed in our outpatient center who underwent transplantation between 1988 and 2015. A total of 50.7% of the patients were male. At the time of surgery, patients' mean age was 37.38 ± 7.44 years. Patients were diagnosed with DM1 at an average of 25 ± 6.08 years before SPKT. For 21.9% of patients, the transplant was done preemptively. Most (91.8%) had enteric drainage. All patients received induction of immunosuppression (either polyclonal immunoglobulins anti-thymocyte globulin or thymoglobulin [64.4%] or monoclonal globulins daclizumab or basiliximab [35.6%]). Patient survival at 1, 5, 10, 15 years was 99%, 97%, 89%, and 75%; kidney survival was 99%, 96%, 84%, and 67%; and pancreas survival was 95%, 92%, 84%, and 64%, respectively. There was a notable tendency toward increased creatinine level (from 1.18 at 1 year to 1.78 at 15 years) and decreased hemoglobin level (from 13.84 at 1 year to 12.65 at 15 years). Diabetic patients with ESRD have a poor prognosis without transplantation. SPKT provides marked prolongation of the patient's life and freedom from insulin injections. Enteric drainage is currently the surgical technique of choice. SPKT should remain as the treatment of choice in this patient population.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065834986

Download citation: RISBibTeXText

PMID: 30177123

DOI: 10.1016/j.transproceed.2018.02.140


Related references

Analysis of Hospitalizations in Simultaneous Pancreas-Kidney Transplant Recipients: A Single-center Experience in Poland. Transplantation Proceedings 50(7): 2132-2135, 2018

Polyomavirus-associated nephropathy in simultaneous kidney-pancreas transplant recipients: a single-center experience. Transplantation Proceedings 36(4): 1097-1098, 2004

Long-term outcomes in simultaneous kidney-pancreas transplant recipients. Transplantation Proceedings 30(4): 1564-1565, 1998

Long-term outcome in kidney transplant recipients over 70 years in the Eurotransplant Senior Kidney Transplant Program: a single center experience. Transplantation 92(2): 210-216, 2011

Simultaneous pancreas-kidney transplant: a single-center long-term outcome. Journal of Nephrology 20(2): 173-176, 2007

Long-Term Outcomes of Kidney and Simultaneous Pancreas-Kidney Transplantation in Recipients With Type 1 Diabetes Mellitus: Silesian Experience. Transplantation Proceedings 48(5): 1681-1686, 2016

Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage. American Journal of Kidney Diseases 38(1): 132-143, 2001

One hundred one simultaneous pancreas-kidney transplantations: long-term outcomes at a single center. Transplantation Proceedings 41(6): 2463-2465, 2010

Long-Term Outcomes of Kidney Transplant Recipients with Bladder Dysfunction: A Single-Center Study. Annals of Transplantation 21: 222-234, 2016

Obstetric and long-term kidney outcomes in renal transplant recipients: a 40-yr single-center study. Clinical Transplantation 30(6): 673-681, 2016

Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center. Clinical Transplantation 26(2): 267-274, 2012

Long-term survival (>25 years) of deceased donor kidney transplant recipients: a single-center experience. Transplantation Proceedings 47(4): 967-970, 2015

Long-Term Outcomes among Kidney Transplant Recipients and after Graft Failure: A Single-Center Cohort Study in Brazil. Biomed Research International 2019: 7105084, 2019

Long-term survival after simultaneous pancreas-kidney transplantation with primary function of at least one year--a single-center experience. Annals of Transplantation 19: 106-111, 2014

Factors and outcomes in association with sepsis differ between simultaneous pancreas/kidney and single kidney transplant recipients. Transplant Infectious Disease 20(2): E12848, 2018